Gri Bio Inc.
13F holders, Q4 2024 (December 31)8holders +1
2new positions
2sold out
$0.83avg. 13F price*
At the end of Q4 2024, 8 institutions reported holding Gri Bio Inc. in their 13F filings, up 1 from Q3 2024. 2 opened new positions and 2 sold out. The largest holders were UBS Group AG ($76K), Geode Capital Management, LLC ($63K) and Virtu Financial LLC ($25K).
- Company
- Gri Bio Inc.
- CUSIP
- 3622AW304
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $38K |
| Exits | 2 | $17K |
All 13F filers, Q3 2024 → Q4 2024: 131,247 shares bought and 47,211 shares sold, net +84,036 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| UBS Group AG | 0.00% | Add +28.8% | 92,267 | $76K |
| Geode Capital Management, LLC | 0.00% | Add +543.0% | 76,182 | $63K |
| Virtu Financial LLC | 0.00% | New | 30,381 | $25K |
| Two Sigma Securities, LLC | 0.00% | New | 15,861 | $13K |
| BlackRock, Inc. | 0.00% | No change | 3,596 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -21.8% | 3,490 | $3K |
| SBI Securities Co., Ltd. | 0.00% | — | 2,001 | $2K |
| Bank of America Corp. | 0.00% | Add +217.4% | 73 | $60 |
"% of holder's portfolio" is GRI BIO INC's weight in each manager's 13F, not the share of Gri Bio Inc. the manager owns.